IUC26680-87

Abstract Code: IUC26680-87   Reducing Infection Risk During Intravesical BCG Through Nitrofurantoin Prophylaxis and Patient Education M. Obat 1, A. Njambi 2, M. Osoo 1, H. Musau 3, P. Girisa 3, S. Muma 1, C. Mwakio 4 (1) AIC kijabe Hospital – Kenya, (2) AIC...

IUC26676-92

Abstract Code: IUC26676-92   HER2-low expression and cell proliferation in urinary bladder carcinomas M. Dumitru 1, M. Hortopan 2, M. Mihaila 3, C.M. Hotnog 3, L.I. Brasoveanu 3, M.E. Panait 1, M.M. Vasilescu 1 (1) Institute of Oncology “Prof. Dr. Al....

IUC26670-86

Abstract Code: IUC26670-86   Radiotherapy Access Gaps for Bladder and Prostate Cancer in East Java, Indonesia S. Harsono 1, G.B. Prajogi 2 (1) Kabupaten Kediri General Hospital, Kediri – Indonesia, (2) Department of Radiotherapy, Cipto Mangunkusumo General...

IUC26652-86

Abstract Code: IUC26652-86   Clinical impact and safety profile of Enfortumab-vedotin: evaluate the efficacy and safety outcomes obtained in patients diagnosed with metastatic urothelial carcinoma undergoing treatment with Enfortumab Vedotin.  J. Gonzalez...

IUC26600-79

Abstract Code: IUC26600-79    ‘STATE-OF-THE-NATION’ STUDY: UNDERSTANDING NHS TREATMENT PATHWAY TO ADVANCE HR NMIBC PATIENT CARE in the UK (SPAN UK) J. Aning 1, J. Catto 2, R. Martin 3, K. Chatterton 4, P. Mariappan 5, S. Mccormack 6, S. Gill 7, B. Szabados 8 (1)...

IUC26590-87

Abstract Code: IUC26590-87   Outcomes of Novel Systemic Therapies in Advanced Upper Tract Urothelial Carcinoma: A systematic Review and Meta-Analysis A. D’arienzo 1, D. Incognito 2, S. Facchini 3, C. Barraco 1, A. Nicastro 1, M. Berretta 4, G. Facchini 1...
error: Content is protected !!